drugset / Trial / NCT03826485
Safety, Pharmacokinetic Study of PRIC in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is Safety, Pharmacokinetic Study of PRIC
Timeline
- Start
- 2019-04-01
- Primary completion
- 2019-04-25
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pranlukast hydrate | Unknown | 50 mg | — |
| Subject | Pranlukast hydrate | Unknown | 225 mg | — |
Indications
No indication recorded.